-
Loading metrics
Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies
- Kevin Randall ,
-
Neil Henderson ,
* E-mail: neil.henderson@astrazeneca.com
¶‡ These authors are joint first authors on this work.
Affiliation AstraZeneca R&D, Mölndal, Sweden
⨯ - Jaimini Reens,
- Sonia Eckersley,
- Ann-Christin Nyström,
- Marie C. South,
- Clare A. Balendran,
- Gerhard Böttcher,
- Glen Hughes,
- Sally A. Price
http://orcid.org/0000-0003-1936-0068
Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies
- Kevin Randall,
- Neil Henderson,
- Jaimini Reens,
- Sonia Eckersley,
- Ann-Christin Nyström,
- Marie C. South,
- Clare A. Balendran,
- Gerhard Böttcher,
- Glen Hughes,
- Sally A. Price
x
- Published: September 6, 2016
- https://doi.org/10.1371/journal.pone.0162076